PRESCRIBER PROFILE AND POSTMARKETING SURVEILLANCE

被引：2

|

作者：

INMAN, WHW

PEARCE, G

机构：

[1] Drug Safety Research Unit, Southampton, S03 8BA, Bursledon Hall

来源：

LANCET | 1993年 / 342卷 / 8885期

关键词：

D O I：

10.1016/0140-6736(93)92973-W

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：1491 / 1491

页数：1

相关论文

共 50 条

[41] Postmarketing surveillance of perindopril in Australia
Morgan, T
CLINICAL DRUG INVESTIGATION, 1996, 12 (03) : 127 - 134
[42] POSTMARKETING SURVEILLANCE - BEYOND MEDWATCH
FAICH, GA
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (18): : 2180 - 2180
[43] CEFMETAZOLE POSTMARKETING SURVEILLANCE IN JAPAN
SAITO, A
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 : 131 - 139
[44] Postmarketing surveillance of sofosbuvir in Egypt
Reactions Weekly, 2015, 1547 (1) : 3 - 3
[45] WORLDWIDE POSTMARKETING DRUG SURVEILLANCE
VENULET, J
REVUE DE MEDECINE INTERNE, 1986, : 52 - 56
[46] ICD Leads and Postmarketing Surveillance
Carlson, Mark D.
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10): : 967 - 967
[47] Postmarketing surveillance for drug safety
Holden, WL
Scarazzini, LJ
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (05) : 503 - 503
[48] DATA QUALITY IN POSTMARKETING SURVEILLANCE
GIRARD, M
ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1986, 5 (02): : 87 - 95
[49] POSTMARKETING SURVEILLANCE OF DRUGS - REPLY
ROESER, HP
ROHAN, AP
MEDICAL JOURNAL OF AUSTRALIA, 1991, 154 (08) : 567 - 567
[50] Passive postmarketing surveillance not enough
Reactions Weekly, 2000, 807 (1) : 4 - 4

← 1 2 3 4 5 →